Nob1e2-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-1-Isoindolinone Derivatives. PartI: Synthesis and SAR Studies for the Inhibition of TNF-$\alpha$ Production

  • Park, Joon-Seok (Institute of Bioscience & Biotechnology, Daewoong Pharm Co.,) ;
  • Baik, Kyong-Up (Institute of Bioscience & Biotechnology, Daewoong Pharm Co.,) ;
  • Cho, Jae-Youl (Institute of Bioscience & Biotechnology, Daewoong Pharm Co.,) ;
  • Yoo, Eun-Sook (Institute of Bioscience & Biotechnology, Daewoong Pharm Co.,) ;
  • Byun, Young-Seok (Institute of Bioscience & Biotechnology, Daewoong Pharm Co.,) ;
  • Park, Myung-Hwan (Institute of Bioscience & Biotechnology, Daewoong Pharm Co.,)
  • Published : 2001.10.01

Abstract

This study describes the synthesis and in vitro evaluation of noble 2-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-isoindolinone Derivatives for the inhibition of TNF-$\alpa$ production. Among these compounds, 2- [3- (Cyclopentyloxy)- 4- methoxyphenyll- 3- methyl -1 - isoindolinone (5) was the most potent in inhibitory activity of TNF-$\alpa$ production in LPS-stimulated RAW264.7 cells.

Keywords

References

  1. Arch. Pharm. Res. v.21 Inhibitory effect of lignans from the rhizomes of Coptis japonica var.dissecta on tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW264.7 cells. Cho,J.Y.;Park,J.;Yoo,E.S.;Yoshikawa,K.;Baik,K.U.;Lee,J.S.;Park,M.H.
  2. Immunology Today v.28 Taming TNF:strategies to restrain this proinflammatory cytokine Eigler,A.;Sinha,B.;Hartmann,G.;Endres, S.
  3. Ann. Rheum. Dis. v.58 no.Suppl1 Etanercept:therapeutic use in patients with rheumatoid arthritis Garrison,L.;McDonnell,N.D.
  4. Ann. Rheum. Dis. v.58 no.Suppl1 Summary of clinical trials in rheumatoid arthritis using infliximab,an anti-TNF alpha treatment Harriman,G.;Harper,L.K.;Schaible,T.F.
  5. J. Med. Chem. v.42 Therapeutic potential and strategies for inhibiting tumor necrosis factoralpha Newton,R.C.;Decicco,C.P.
  6. Kor. J. Med. Chem. v.10 Syntheses and biological evaluation of novel compounds for the inhibition of TNF-α production Park,J.S.;Baik,K.U.;Son,H.J.;Cho,J.Y.;Park,J.;Lee,J.H.;Lee,S.J.;Yoo,E.S.;Park,M.H.
  7. Arch. Pharm. Res. v.23 Synthesis and structure-activity relationships of novel compounds for the inhibition of TNF-α production Park,J.S.;Baik,K.U.;Son,H.J.;Cho,J.Y.;Park,J.;Lee,J.H.;Lee,S.J.;Yoo,E.S.;Byun,Y.S.;Park,M.H.